BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+3.35%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.4B
AUM Growth
+$17.4B
(+0.42%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
90.2%
Holding
115
New
7
Increased
16
Reduced
13
Closed
14
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$28.6M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$20.8M |
| 3 |
AbCellera Biologics
ABCL
|
$19.8M |
| 4 |
Denali Therapeutics
DNLI
|
$17.3M |
| 5 |
Immunovant
IMVT
|
$16.3M |
Top Sells
| 1 |
argenx
ARGX
|
$63.4M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$55.9M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$48.1M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$28.7M |
| 5 |
AnaptysBio
ANAB
|
$12M |
Sector Composition
| 1 | Healthcare | 99.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Taysha Gene Therapies
TSHA
$791M
| $7.92M | 0.05% |
+2,504,756
| New | +$7.92M |
|
52
Sana Biotechnology
SANA
$759M
| $7.74M | 0.04% |
2,000,000
| – | – |
|
|
BLUE
53
DELISTED
bluebird bio
BLUE
| $7.6M | 0.04% |
2,499,715
| – | – |
|
54
ARS Pharmaceuticals
SPRY
$1.08B
| $7.58M | 0.04% |
2,006,451
| – | – |
|
55
Sagimet Biosciences
SGMT
$239M
| $7.18M | 0.04% |
+815,359
| New | +$7.18M |
|
56
TScan Therapeutics
TCRX
$106M
| $7.13M | 0.04% |
2,784,792
| – | – |
|
57
Geron
GERN
$893M
| $6.49M | 0.04% |
3,061,224
| – | – |
|
58
Athira Pharma
ATHA
$15.5M
| $6.37M | 0.04% |
3,153,807
| – | – |
|
59
Alector
ALEC
$282M
| $6.25M | 0.04% |
964,851
| – | – |
|
60
Mirum Pharmaceuticals
MIRM
$3.75B
| $6.02M | 0.03% |
+190,476
| New | +$6.02M |
|
61
Edgewise Therapeutics
EWTX
$1.54B
| $6.01M | 0.03% |
1,049,699
+549,699
| +110% | +$3.15M |
|
62
Summit Therapeutics
SMMT
$17.5B
| $5.87M | 0.03% |
3,140,473
-3,164,232
| -50% | -$5.92M |
|
63
Stoke Therapeutics
STOK
$1.08B
| $5.85M | 0.03% |
1,485,915
-644,323
| -30% | -$2.54M |
|
|
HOOK
64
DELISTED
HOOKIPA Pharma
HOOK
| $4.97M | 0.03% |
8,065,398
+3,639,863
| +82% | +$2.24M |
|
|
MORF
65
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.94M | 0.03% |
+215,800
| New | +$4.94M |
|
66
Celcuity
CELC
$2.3B
| $4.89M | 0.03% |
+535,478
| New | +$4.89M |
|
67
Neurogene
NGNE
$284M
| $4.82M | 0.03% |
1,221,414
-2,600,326
| -68% | +$1.81M |
|
|
WHWK
68
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $4.79M | 0.03% |
989,928
| – | – |
|
|
OPT
69
DELISTED
Opthea Limited American Depositary Shares
OPT
| $4.69M | 0.03% |
2,690,891
-500
| -0% | -$871 |
|
70
Natera
NTRA
$23B
| $4.43M | 0.03% |
100,000
| – | – |
|
71
Design Therapeutics
DSGN
$339M
| $3.54M | 0.02% |
1,500,000
+1,000,000
| +200% | +$2.36M |
|
72
Praxis Precision Medicines
PRAX
$980M
| $3.21M | 0.02% |
1,879,915
| – | – |
|
73
Compass Therapeutics
CMPX
$466M
| $3.07M | 0.02% |
1,557,630
| – | – |
|
|
TLIS
74
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $2.93M | 0.02% |
508,323
-7,116,512
| -93% | +$6 |
|
|
GRCL
75
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $2.88M | 0.02% |
1,000,000
| – | – |
|